Pharmaceutical intermediates

Tenapanor Hydrochloride Intermediates

4 pharmaceutical intermediates for Tenapanor Hydrochloride. Indication: Hyperphosphatemia; chronic renal insufficiency; constipation; irritable bowel syndrome.

提交项目 All intermediates

About Tenapanor Hydrochloride

Originator: Ardelyx, Inc
Indication: Hyperphosphatemia; chronic renal insufficiency; constipation; irritable bowel syndrome
Approved Date: 09/12/2019
DS/DP: 12/30/2029

Available intermediates

4 intermediates currently listed for Tenapanor Hydrochloride. Request specifications, documentation or a quotation for any item below.

Tenapanor Hydrochloride intermediates
Product Name	CAS No.	Molecular Formula	Physical Properties
Isoquinoline, 4-(3-bromophenyl)-6,8-dichloro-1,2,3,4-tetrahydro-2-methyl-, (4S)-	1870821-29-6	/	/
4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline	543737-10-6	/	/
Boc-1-amino-3,6-dioxa-8-octanediamine	153086-78-3	/	/
(2,4-Dichlorobenzyl)methylamine	5013-77-4	/	/

Other programs under T

Tazemetostat Hydrobromide Tazobactam Sodium Tegoprazan Teneligliptin Tetrabenazine Tezacaftor Tianeptine sodium salt Ticagrelor

Building toward Tenapanor Hydrochloride?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →